Description
The E479K variant has been published as a pathogenic variant in a single, 18 year old female with ptosis and severe mild restriction of horizontal eye movements; however, supporting functional information is not available (Virgilio, R et al., 2008). The E479K variant has not been reported as a benign polymorphism to our knowledge. The E479K variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The E479K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in nearby residues (W474S/C, A475D/P/T, F478C/I, F485L) have been reported in the Human Gene Mutation Database in association with progressive external opthalmoplegia (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is a strong candidate for a pathogenic variant, however the possibility that it is a benign variant cannot be excluded.
| # | Sample | Method | Observation |
|---|
| Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
|---|
| 1 | germline | yes | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |
